RxDoctor Payments Data

Marissa McClement, PA

Surgical · Hartford, CTNPI 1275210767

Payments from drug & device makers

$1,111in general payments, 2019–2025

Across 24 payments — averaging $46.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Getinge USA Sales, LLC$385
  • Edwards Lifesciences$202
  • Abiomed$200
  • Bolton Medical Inc$137
  • AstraZeneca$103
  • Lemaitre Vascular, Inc.$36
  • plus $46 from 2 others

What the payments were for

  • Travel & lodging$20819%
  • Food & beverage$90281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Getinge USA Sales, LLC11$385
Edwards Lifesciences5$202
Abiomed2$200
Bolton Medical Inc1$137
AstraZeneca1$103
Lemaitre Vascular, Inc.2$36
Solventum Corporation1$29
Terumo Cardiovascular Systems Corporation1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,111 in reported general payments places this provider in the 75th percentile of 568 surgical providers in Connecticut.

See all surgical providers in Connecticut

Medicare billing

Part B allowed, 2024
$2,407
Medicare patients
14
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate21$279

Paid to pharmacies, not to this prescriber.

Other surgical in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →